Hormone withdrawal-associated symptoms with ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 µg/desogestrel 150 µg (21/7 regimen)

• Hoofdauteurs: Bitzer J (Auteur), Banal-Silao MJ (Auteur), Ahrendt HJ (Auteur), Restrepo J (Auteur), Hardtke M (Auteur), Wissinger-Graefenhahn U (Auteur), Trummer D (Auteur)
• Formaat: Boek
• Gepubliceerd in: Dove Medical Press, 2015-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Johannes Bitzer,1 Maria Jesusa Banal-Silao,2 Hans-Joachim Ahrendt,3 Jaime Restrepo,4 Marion Hardtke,5 Ulrike Wissinger-Graefenhahn,6 Dietmar Trummer7 1Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, Switzerland; 2University of the Philippines College of Medicine, Manila...